Ho‐Min Chen

2.0k total citations
97 papers, 1.5k citations indexed

About

Ho‐Min Chen is a scholar working on Oncology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Ho‐Min Chen has authored 97 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 20 papers in Surgery and 18 papers in Pathology and Forensic Medicine. Recurrent topics in Ho‐Min Chen's work include Bone health and osteoporosis research (9 papers), International Business and FDI (9 papers) and Health Systems, Economic Evaluations, Quality of Life (8 papers). Ho‐Min Chen is often cited by papers focused on Bone health and osteoporosis research (9 papers), International Business and FDI (9 papers) and Health Systems, Economic Evaluations, Quality of Life (8 papers). Ho‐Min Chen collaborates with scholars based in Taiwan, China and Japan. Ho‐Min Chen's co-authors include Chia‐Wen Hsu, Yung-Chih Lien, Szu‐Yuan Wu, Yu‐Yun Shao, Ann‐Lii Cheng, Mei‐Shu Lai, Fei‐Yuan Hsiao, Chang-Yun Lu, Jiaqiang Zhang and Zhong‐Zhe Lin and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Blood.

In The Last Decade

Ho‐Min Chen

92 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ho‐Min Chen Taiwan 21 472 320 203 195 154 97 1.5k
Xiaoge Zhou China 14 240 0.5× 317 1.0× 60 0.3× 156 0.8× 89 0.6× 66 1.3k
Hendrik Van den Berg United States 21 148 0.3× 152 0.5× 553 2.7× 347 1.8× 69 0.4× 66 1.8k
Ian Fraser United Kingdom 25 292 0.6× 225 0.7× 98 0.5× 277 1.4× 591 3.8× 105 2.2k
Jun Ho Lee South Korea 17 162 0.3× 165 0.5× 31 0.2× 181 0.9× 168 1.1× 51 1.1k
Michael Klein Austria 23 322 0.7× 71 0.2× 305 1.5× 114 0.6× 251 1.6× 98 1.7k
Peter Thompson United States 25 116 0.2× 188 0.6× 387 1.9× 223 1.1× 432 2.8× 64 2.5k
Jan Fichtner Germany 26 287 0.6× 129 0.4× 281 1.4× 404 2.1× 514 3.3× 99 2.0k
Abel François France 18 214 0.5× 81 0.3× 296 1.5× 26 0.1× 187 1.2× 107 1.4k
Anne E. Nelson Australia 21 125 0.3× 311 1.0× 34 0.2× 121 0.6× 72 0.5× 51 1.6k
James A. Wolff United States 26 541 1.1× 238 0.7× 189 0.9× 434 2.2× 196 1.3× 99 2.8k

Countries citing papers authored by Ho‐Min Chen

Since Specialization
Citations

This map shows the geographic impact of Ho‐Min Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ho‐Min Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ho‐Min Chen more than expected).

Fields of papers citing papers by Ho‐Min Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ho‐Min Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ho‐Min Chen. The network helps show where Ho‐Min Chen may publish in the future.

Co-authorship network of co-authors of Ho‐Min Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Ho‐Min Chen. A scholar is included among the top collaborators of Ho‐Min Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ho‐Min Chen. Ho‐Min Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Ho‐Min, et al.. (2025). Higher nonunion rates with locking plates compared to dynamic compression plates in forearm diaphyseal fractures: a multicenter study. Journal of Orthopaedics and Traumatology. 26(1). 10–10.
2.
Hsiao, Fei‐Yuan, et al.. (2025). Burden of herpes zoster in adults by age, sex, and underlying conditions in Taiwan: A retrospective cohort study, 2011–2020. Human Vaccines & Immunotherapeutics. 21(1). 2570571–2570571. 1 indexed citations
3.
4.
Hsiao, Fei‐Yuan, Yi‐Chin Lin, Ho‐Min Chen, et al.. (2024). Effect of frailty on effectiveness and safety of GLP-1 receptor agonists versus SGLT2 inhibitors in people with type 2 diabetes in Taiwan: a retrospective, nationwide, longitudinal study. The Lancet Healthy Longevity. 5(9). 100621–100621. 10 indexed citations
5.
Lee, Wei‐Ju, Wen-Kuang Yu, Wei‐Chih Chen, et al.. (2024). Activin A as a potential biomarker for preserved ratio impaired spirometry (PRISm) and clinical outcomes in community-dwelling adults. Archives of Gerontology and Geriatrics. 126. 105539–105539. 1 indexed citations
6.
Huang, Chun‐Feng, Ho‐Min Chen, Chih‐Hsing Wu, et al.. (2023). Osteoporosis care after hip fracture: Observation from national health insurance database and fracture liaison services. Journal of the Formosan Medical Association. 122. S74–S81. 2 indexed citations
7.
Kojima, Taro, Yusuke Suzuki, Shao-En Weng, et al.. (2023). Medication overload: A closer look at polypharmacy and potentially inappropriate medications among older people in Taiwan and Japan. Archives of Gerontology and Geriatrics. 115. 105100–105100. 5 indexed citations
8.
9.
Hu, Fung‐Rong, Chung‐May Yang, Chang‐Hao Yang, et al.. (2021). Metabolic Syndromes as Important Comorbidities in Patients of Inherited Retinal Degenerations: Experiences from the Nationwide Health Database and a Large Hospital-Based Cohort. International Journal of Environmental Research and Public Health. 18(4). 2065–2065. 2 indexed citations
10.
Zhang, Jiaqiang, Chang-Yun Lu, Ho‐Min Chen, & Szu‐Yuan Wu. (2020). Pathologic response rates for breast cancer stages as a predictor of outcomes in patients receiving neoadjuvant chemotherapy followed by breast-conserving surgery. Surgical Oncology. 36. 91–98. 10 indexed citations
11.
Zhang, Jiaqiang, Chang-Yun Lu, Lei Qin, Ho‐Min Chen, & Szu‐Yuan Wu. (2020). Breast-conserving surgery with or without irradiation in women with invasive ductal carcinoma of the breast receiving preoperative systemic therapy: A cohort study. The Breast. 54. 139–147. 19 indexed citations
12.
13.
Huang, Eng‐Yen, Hao Lin, Ho‐Min Chen, Wan‐Ming Chen, & Szu‐Yuan Wu. (2020). Outcomes of Definitive Concurrent Chemoradiotherapy for Cervical Squamous Cell Carcinoma and Adenocarcinoma: Overall Survival, Locoregional Recurrence, and Distant Metastasis. SSRN Electronic Journal. 1 indexed citations
14.
Huang, Shao‐Yi, et al.. (2020). Economic burden of cancers in Taiwan: a direct and indirect cost estimate for 2007–2017. BMJ Open. 10(10). e036341–e036341. 27 indexed citations
15.
Lin, Ting‐Tse, et al.. (2019). Direct Comparison of Low-Dose Dabigatran and Rivaroxaban for Effectiveness and Safety in Patients with Non-Valvular Atrial Fibrillation.. Europe PMC (PubMed Central). 35(1). 42–54. 7 indexed citations
16.
Huang, Huai‐Hsuan, Fei‐Yuan Hsiao, Li‐Ju Chen, Ho‐Min Chen, & Bor‐Sheng Ko. (2018). Women with Diffuse Large B Cell Lymphoma Benefit More from Rituximab-Containing Chemotherapy. Journal of Women s Health. 28(2). 203–211. 5 indexed citations
17.
Lai, Chao‐Lun, Ho‐Min Chen, Min‐Tsun Liao, & Ting‐Tse Lin. (2017). Abstract 15366: Comparative Effectiveness and Safety Between Reduced Dose Dabigatran, Reduced Dose Rivaroxaban and Warfarin Among Oldest Old Atrial Fibrillation Patients. Circulation. 1 indexed citations
18.
Lai, Chao‐Lun, et al.. (2015). Risk of hip/femur fractures during the initiation period of α‐adrenoceptor blocker therapy among elderly males: a self‐controlled case series study. British Journal of Clinical Pharmacology. 80(5). 1208–1218. 9 indexed citations
19.
Shao, Yu‐Yun, Ho‐Min Chen, Zhong‐Zhe Lin, et al.. (2015). Young patients with colorectal cancer have increased risk of second primary cancers. Japanese Journal of Clinical Oncology. 45(11). 1029–1035. 14 indexed citations
20.
Shao, Yu‐Yun, Wen‐Yi Shau, Zhong‐Zhe Lin, et al.. (2012). Comparison of gefitinib and erlotinib efficacies as third-line therapy for advanced non-small-cell lung cancer. European Journal of Cancer. 49(1). 106–114. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaoge Zhou Breakdown of academic impact, for papers by Hendrik Van den Berg Breakdown of academic impact, for papers by Ian Fraser Breakdown of academic impact, for papers by Jun Ho Lee Breakdown of academic impact, for papers by Michael Klein Breakdown of academic impact, for papers by Peter Thompson Breakdown of academic impact, for papers by Jan Fichtner Breakdown of academic impact, for papers by Abel François Breakdown of academic impact, for papers by Anne E. Nelson Breakdown of academic impact, for papers by James A. Wolff
Rankless by CCL
2026